Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492541 · ClinicalTrials.gov registry record · NA
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT03492541: Completed NA study, sponsored by Alcon Research.
NCT03492541 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03492541, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the clinical effectiveness and tolerability of SYSTANE® Complete in adult patients with dry eye disease. Fluorescein-stained tear film break-up time (TFBUT) will be evaluated as the primary objective.
Primary Outcome
TFBUT will be assessed using fluorescein, an ocular staining dye
Interventions
- OTHER Propylene glycol-based eye drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2019-05-14 |
| Phase | NA |
What the finished NCT03492541 record still lists
NCT03492541 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Propylene glycol-based eye drops is the first listed.
NCT03492541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03492541 about?
NCT03492541 is a clinical study titled "Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease". The purpose of this study is to evaluate the clinical effectiveness and tolerability of SYSTANE® Complete in adult patients with dry eye disease. Fluorescein-stained tear film break-up time (TFBUT) will be evaluated as the primary objective.
What is the current status of trial NCT03492541?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2018-07-18. Estimated completion is 2019-05-14.
What interventions are being tested in trial NCT03492541?
The interventions under investigation include: Propylene glycol-based eye drops (OTHER).
Who is sponsoring clinical trial NCT03492541?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03492541's enrollment target sits among peer trials
134 728th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI